Fingerprint
Dive into the research topics of 'A phase III trial of tirasemtiv as a potential treatment for amyotrophic lateral sclerosis'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
A phase III trial of tirasemtiv as a potential treatment for amyotrophic lateral sclerosis
on behalf of the VITALITY-ALS STUDY GROUP
Research output: Contribution to journal › Article › peer-review
24
Downloads
(Pure)